News

Company News

Press Release

14

2018/09

Press Conference of Jiuzhitang Qihang Fund’s Investment in Stemdica Cell Technologies, Inc.

On 14 September 2018, Press Conference - Jiuzhitang Qihang Fund’s Investment in Stemdica Cell Technologies, Inc. & Global Stem Cell Industry Development Summit was held in Beijing.

05

2021/08

Stemedica Cell Technologies, Inc., a US company with investment from JZT, started recruiting patients for its Phase II COVID-19 study.

25

2021/02

Jiuzhitang Maker received fund support from Daxing District Program for Advancing Transfer and Transformation of Technological Achievements.

12

2021/01

China’s first clinical trial treating ischemic stroke with an imported stem cell product was formally launched.

19

2020/12

Jiuzhitang Maker was awarded the prize of "Excellent Enterprise Assuming Social Responsibilities in 2020" by Health News.

18

2020/12

Jiuzhitang Maker was officially recognized as a company qualified to establish a postdoctoral station.

< 1234...12 >